
	International Journal of Pharmacology
	Year: 2018 \| Volume: 14 \| Issue: 6 \| Page No.: 866-872 DOI: 10.3923/ijp.2018.866.872

Salvianolic Acid B Administration Attenuate Bone Loss in Ovariectomy Induced Rat Model

Yuanyuan Liu and Haili Shen

Abstract: Background and Objective: Osteoporosis is a chronic progressive skeletal disorder characterized by low Bone Mass Density (BMD) and bone quality. This study was aimed to access the anti-osteoporotic effects of salvianolic acid B (SAB-B) against ovariectomy-induced in rat model. Materials and Methods: Forty female (n = 40) rats were randomly chosen and divided into four groups as sham-operated control (underwent bilateral laparotomy; sham group, n=10), whereas rats underwent laparotomy followed by bilateral ovariectomy (ovariectomy model group; OVX, n= 10). Whereas, OVX underwent rats were orally supplemented with either 20 or 40 mg kg^–1 of SAB-B (OVX+20 or 40 mg kg^–1 SAB-B group; n= 10) for 12 weeks after 4 weeks of OVX. Statistical difference between the experimental groups were analyzed by student t-test using SPSS software at p<0.05. Results: Treatment with SAB-B (20 or 40 mg kg^–1), substantially increased the body weight than OVX rats. A pronounced elevation in the levels of Bone Mineral Density/Content (BMD/BMC) and body weight were observed in SAB-B treated group as compared to OVX group. Bone markers like deoxypyridinoline, alkaline phosphatase and osteocalcin as well as inflammatory markers like IL-1β, IL-6, TNF-α concentrations were significantly abolished after 12 weeks of administration with SAB-A in OVX rats. Furthermore, the bone biomechanical stability was notably improved upon supplementation with SAB-B. Conclusion: Both SAB-B 20 and 40 mg kg^–1 treatment exhibit potent anti-osteoporotic activity, nevertheless SAB-B 40 showed superior anti-osteoporotic activity than SAB-B 20. Therefore, SAB-B would be recommended for treating post-menopausal osteoporosis with other standard drugs.

PDF Fulltext XML References Citation Report Citation

RELATED ARTICLES:

•	Chemoprotective Efficacy of Salvianolic Acid B via Triggering Apoptosis in MCF-7 Human Breast Cancer Cells

•	An Evidence-Based Review of Micro-CT Assessments of the Postmenopausal Osteoporosis Rat Model

•	Efficacy of L-Carnitine in the Treatment of Osteoporosis in Men

How to cite this article:

Yuanyuan Liu and Haili Shen, 2018. Salvianolic Acid B Administration Attenuate Bone Loss in Ovariectomy Induced Rat Model. International Journal of Pharmacology, 14: 866-872.

DOI: 10.3923/ijp.2018.866.872

URL: https://scialert.net/abstract/?doi=ijp.2018.866.872

COMMENT ON THIS PAPER

Navigation


		Online First
		Current Issue
		Previous Issues
		Editorial Board
		Submit a Manuscript
		Guide to Authors
		Subscribe to E-alerts

Indexed In


		ASCI-Database
		Asian Digital Library
		Chemical Abstract Services
		EMBASE
		Google Scholar
		ISI Web of Knowledge
		Science Citation Index (EXP)
		SCIMAGO
		Thomson ISI

Science Alert